Xarelto 15 mg film-coated tablets

Company
Bayer Limited
Active Ingredient
Dosage Form
Film-coated tablet
Legal Category
B - prescription, may be renewed
Date of revision
06/2024

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/08/472/011 15 milligram(s) B01AF, B01AF01 Film-coated tablet
EU/1/08/472/012 15 milligram(s) B01AF, B01AF01 Film-coated tablet
EU/1/08/472/013 15 milligram(s) B01AF, B01AF01 Film-coated tablet
EU/1/08/472/014 15 milligram(s) B01AF, B01AF01 Film-coated tablet
EU/1/08/472/015 15 milligram(s) B01AF, B01AF01 Film-coated tablet
EU/1/08/472/016 15 milligram(s) B01AF, B01AF01 Film-coated tablet
Licence number
EU/1/08/472/011
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet
Licence number
EU/1/08/472/012
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet
Licence number
EU/1/08/472/013
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet
Licence number
EU/1/08/472/014
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet
Licence number
EU/1/08/472/015
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet
Licence number
EU/1/08/472/016
Strength
15 milligram(s)
ATC Code
B01AF, B01AF01
Dosage Form
Film-coated tablet

Bayer Limited

1st Floor The Grange Offices, The Grange, Brewery Road, Stillorgan, Co. Dublin, A94 H2K7, Ireland

Telephone
+35312163300
Email
Medinfo.ireland@bayer.com